Markku Pasanen
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Obstetrics and Gynecology top 1%
- Pregnancy and preeclampsia studies
Papers in
- Pharmacology 70
- Pharmacogenetics and Drug Metabolism 66
- Drug-Induced Hepatotoxicity and Protection 19
-
- Glutathione Transferases and Polymorphisms 14
- Co-authors
- Olavi Pelkonen (47 shared papers)Hannu Raunio (30 shared papers)Risto O. Juvonen (29 shared papers)Jukka Hakkola (8 shared papers)Päivi Myllynen (3 shared papers)Seppo Auriola (14 shared papers)Arno J. Arranto (2 shared papers)E. A. Sotaniemi (1 shared paper)
- Journals
- Biochemical Pharmacology (10 papers)Toxicology Letters (9 papers)Placenta (7 papers)Archives of Toxicology (5 papers)Xenobiotica (5 papers)
- Partner nations
- FinlandUnited StatesUnited Kingdom
In The Last Decade
Markku Pasanen
139 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 141
- Pharmacology 1.8k
- Obstetrics and Gynecology 338
- Health, Toxicology and Mutagenesis 642
- Biochemistry 335
- Pediatrics, Perinatology and Child Health 609
Countries citing papers authored by Markku Pasanen
This map shows the geographic impact of Markku Pasanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markku Pasanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markku Pasanen more than expected).
Fields of papers citing papers by Markku Pasanen
This network shows the impact of papers produced by Markku Pasanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markku Pasanen. The network helps show where Markku Pasanen may publish in the future.
Co-authors
The 25 scholars most cited alongside Markku Pasanen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 312 | |
| 2 | 2009 | 209 | |
| 3 | 2000 | 198 | |
| 4 | 2004 | 191 | |
| 5 | 1998 | 181 | |
| 6 | 1996 | 175 | |
| 7 | 2000 | 133 | |
| 8 | 1996 | 133 | |
| 9 | 1988 | 127 | |
| 10 | 1990 | 96 | |
| 11 | 1990 | 94 | |
| 12 | 2007 | 92 | |
| 13 | 1998 | 90 | |
| 14 | 1986 | 87 | |
| 15 | 2007 | 85 | |
| 16 | 1999 | 82 | |
| 17 | 2000 | 80 | |
| 18 | 2007 | 61 | |
| 19 | 2001 | 56 | |
| 20 | 2004 | 51 |
About Markku Pasanen
Markku Pasanen is a scholar working on Pharmacology, Molecular Biology, Biochemistry, Health, Toxicology and Mutagenesis and Oncology, having authored 139 papers that have together received 4.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (66 papers), Drug-Induced Hepatotoxicity and Protection (19 papers), Eicosanoids and Hypertension Pharmacology (19 papers), Glutathione Transferases and Polymorphisms (14 papers), Drug Transport and Resistance Mechanisms (13 papers), Carcinogens and Genotoxicity Assessment (12 papers), Analytical Chemistry and Chromatography (8 papers) and Pregnancy and preeclampsia studies (7 papers). The work is most often cited by research in Pharmacology (1.8k citations), Obstetrics and Gynecology (338 citations), Health, Toxicology and Mutagenesis (642 citations), Biochemistry (335 citations) and Pediatrics, Perinatology and Child Health (609 citations). Markku Pasanen has collaborated with scholars based in Finland, United States and United Kingdom. Frequent co-authors include Olavi Pelkonen, Hannu Raunio, Risto O. Juvonen, Jukka Hakkola, Päivi Myllynen, Seppo Auriola, Arno J. Arranto, E. A. Sotaniemi, Arja Rautio and Kirsi Vähäkangas. Their work appears in journals such as Biochemical Pharmacology, Toxicology Letters, Placenta, Archives of Toxicology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.